celecoxib has been researched along with Cancer, Radiation-Induced in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Over a million nonmelanoma skin cancer cases will be reported in the United States this year alone." | 1.32 | Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. ( Koki, AT; Oberyszyn, TM; Rubal, PA; Wilgus, TA; Zweifel, BS, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laquer, V | 1 |
| Dellinger, RW | 1 |
| Mannering, I | 1 |
| Garcia, AG | 1 |
| Abraham, V | 1 |
| Pavlis, J | 1 |
| Liu-Smith, F | 1 |
| De Feraudy, S | 1 |
| Meyskens, FL | 1 |
| Kelly, KM | 1 |
| Wulff, BC | 1 |
| Thomas-Ahner, JM | 1 |
| Schick, JS | 1 |
| Oberyszyn, TM | 3 |
| Fischer, SM | 3 |
| Conti, CJ | 2 |
| Viner, J | 1 |
| Aldaz, CM | 1 |
| Lubet, RA | 2 |
| Wilgus, TA | 2 |
| Koki, AT | 2 |
| Zweifel, BS | 2 |
| Rubal, PA | 2 |
| Kusewitt, DF | 1 |
| Won, YK | 1 |
| Ong, CN | 1 |
| Shi, X | 1 |
| Shen, HM | 1 |
| Riedel, SB | 1 |
| Sanders, BG | 1 |
| Kline, K | 1 |
| Lo, HH | 1 |
| Gordon, GB | 1 |
| Seibert, K | 1 |
| Kelloff, G | 1 |
| Pentland, AP | 1 |
| Schoggins, JW | 1 |
| Scott, GA | 1 |
| Khan, KN | 1 |
| Han, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Radiosensitization With a COX-2 Inhibitor (Celecoxib), With Chemoradiation for Cancer of the Head and Neck[NCT00581971] | Phase 1/Phase 2 | 30 participants (Actual) | Interventional | 2002-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Evaluate the response to concurrent celecoxib, carboplatin, paclitaxel, and radiotherapy in the treatment of locally advanced SSC of the head and neck. Response is determined by local control only, local and distant metastasis, distant metastasis only, second primary, and surgical salvage. (NCT00581971)
Timeframe: 2 years from end of treatment (Radiation therapy)
| Intervention | Participants (Number) | ||||
|---|---|---|---|---|---|
| Local Control Only | Local Control and Distant Metastasis | Distant Metastatsis Only | Secondary Primary - Site Unknown | Surgical Salvage | |
| Recurrence | 6 | 2 | 1 | 2 | 3 |
Particpants experiencing Acute Toxicities > Grade 3 (NCT00581971)
Timeframe: 2 years from radiation therapy
| Intervention | participants (Number) | ||
|---|---|---|---|
| Hematologic | Dermatitis | Mucositis/Dysphagia | |
| Acute Toxicity | 12 | 7 | 16 |
9 other studies available for celecoxib and Cancer, Radiation-Induced
| Article | Year |
|---|---|
12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Biopsy; Carcinoma, Squamous Cell; Celecoxib; Chemopreven | 2018 |
Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.
Topics: Animals; Blotting, Western; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Cyclosporine; Dinoprost | 2010 |
Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Celecoxib; Cell Division; Cyclooxygenase 2; Disease Progr | 2003 |
Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Topics: Administration, Topical; Animals; Celecoxib; Cell Division; Cyclooxygenase 2; Dinoprostone; Disease | 2003 |
Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; | 2003 |
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Blotting, West | 2004 |
Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice.
Topics: Acetates; Administration, Inhalation; Animals; Antineoplastic Combined Chemotherapy Protocols; Carci | 2008 |
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Celecoxib; Cell Division; Cyclooxygen | 1999 |
Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.
Topics: Animals; Carcinoma, Squamous Cell; Celecoxib; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhi | 1999 |